Clinical Trial Update: A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of ADA-011 for advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ADA-011

Snippet

Sponsor: Adanate, Inc | Conditions: Solid Tumor, Adult | Phase 1 | Status: TERMINATED